| Literature DB >> 10435586 |
H Kohzaki1, K Ito, G Huang, H J Wee, Y Murakami, Y Ito.
Abstract
The chimeric gene, AML1/ETO (MTG8), generated in t(8;21) acute myeloid leukemia enhances the expression of Bcl-2. To evaluate whether this enhancement is the primary role of AML1/ETO in leukemogenesis, effects of over-expression of Bcl-2 in the murine myeloid precursor cell line, 32Dcl3, were examined. When 32Dcl3 cells expressing exogenous Bcl-2 were induced to differentiate, the onset of morphological differentiation was delayed. However, even the cells expressing very high levels of exogenous Bcl-2 eventually underwent differentiation without a significant decrease in the synthesis of Bcl-2. On the contrary, 32Dcl3 cells stably expressing AML1/ETO were completely resistant to differentiation and continued to grow in the presence of G-CSF. These results are consistent with the interpretation that stimulation of Bcl-2 expression is not the primary target of AML1/ETO.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10435586 DOI: 10.1038/sj.onc.1202735
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867